primary cytoreductive surgery

September 21, 2016

Careful Selection of Ovarian Cancer Patients for Chemo Before Surgery May Improve Survival Rates

News

The use of neoadjuvant chemotherapy (NACT), or chemo administered before surgery, in patients with ovarian cancer has increased as an alternative to primary cytoreductive surgery (PCS), performed when a woman ... Read more

August 15, 2016August 15, 2016

New Guidelines for First-Line Chemo Against Advanced Ovarian Cancer Issued

News

According to a new clinical guideline jointly created by the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology, some women with advanced ovarian cancer should receive neoadjuvant chemotherapy as ... Read more